Mexico City /
According to the publication in the New England Journal of Medicine, The vaccine of Janssen, Funded by Johnson & Johnson, Demonstrates greater effectiveness in the application of a single dose. In one study, neutralizing antibodies were detected against virus of wild type in 90 percent of participants on day 29 after the first dose of vaccine.
This is how single-dose effectiveness results outweigh those that require two. In addition, they point out that the antigen can be stored for three months under temperatures of minus 2 to 8 degrees Celsius. and does not require dilution to apply.
It should be noted that the company is working on the development of the vaccine in Mexico and is now preparing to apply for emergency use in our country.
However, these will have to be analyzed organisms such as the Federal Commission for Protection against Health Risks (COFEPRIS) or the Drug and Food Administration (FDA for its acronym in English) in United States.
Status of other vaccines in Mexico
- Pfizer and BioNtech: This vaccine is the one that has already begun to be applied in the health personnel throughout the republic. So far, about 200,000 people have benefited.
- AstraZeneca: In the most recent hours, the first batch of vaccines from this company arrived in Mexico, which has received the green light from COFEPRIS to apply. Private companies are already in the process of acquiring them for marketing and there are talks with the government to join the national brigade.
- Sputnik: The Undersecretary of Prevention and Health Promotion, Hugo López-Gatell, traveled to Argentina a few days ago to test the effectiveness of Sputnik V, Which has paved the way for it to be approved in Mexico in the next few hours. There is already a purchase agreement.